Accounting for more than 90% of all diabetes cases, T2DM is driven by core defects of insulin resistance and progressive β-cell failure (Author anonymous, 2017), peripheral tissues (muscle, adipose, liver) become less sensitive to insulin, impeding insulin-signalling pathways and causing defective glucose uptake and utilization (Mu et al., 2019). This evidence concerns the gene INS and diabetes mellitus.